Comments on: Seres receives FDA orphan drug status for SER-109 to prevent CDI in adults

Comments on: Seres receives FDA orphan drug status for SER-109 to prevent CDI in adults /news/newsseres-receives-fda-orphan-drug-status-for-ser-109-to-prevent-cdi-in-adults-4654054/ The leading site for news and procurement in the pharmaceutical industry Sun, 23 Aug 2015 17:30:00 +0000 hourly 1 https://wordpress.org/?v=6.6.2